Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.
|Number of pages||14|
|Journal||Gut and Liver|
|Publication status||Published - Mar 2014|
- Colorectal cancer
- Colorectal cancer screening
- Fecal immunochemical test for hemoglobin
- Population screening